These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Terms: = Colorectal cancer AND HER1, YOR227W AND Prognosis 6 results:
1. Lapatinib. Voigtlaender M; Schneider-Merck T; Trepel M Recent Results Cancer Res; 2018; 211():19-44. PubMed ID: 30069757 [TBL] [Abstract] [Full Text] [Related]
2. HER family receptor expression and prognosis in pancreatic cancer. Bittoni A; Mandolesi A; Andrikou K; Santoni M; Alfonsi S; Lanese A; Loretelli C; Pellei C; Piva F; Scarpelli M; Cascinu S Int J Biol Markers; 2015 Jul; 30(3):e327-32. PubMed ID: 26109364 [TBL] [Abstract] [Full Text] [Related]
3. Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectalcancers independent of KRAS mutational status. Lee J; Jain A; Kim P; Lee T; Kuller A; Princen F; In-GuDo ; Kim SH; Park JO; Park YS; Singh S; Kim HC PLoS One; 2014; 9(8):e103551. PubMed ID: 25090459 [TBL] [Abstract] [Full Text] [Related]
4. Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation. Luedke E; Jaime-Ramirez AC; Bhave N; Carson WE J Immunother; 2012 Jun; 35(5):367-73. PubMed ID: 22576341 [TBL] [Abstract] [Full Text] [Related]